The Prevalence of Hypoglycemia and Its Impact on The Quality of Life of Type 2 Diabetes Mellitus Patients in Greece (The Hypo Study).

Yfantopoulos, J; Hatzikou, M; Rombopoulos, G; Panitti, E; Latsou, D

Yfantopoulos, J; Hatzikou, M; Rombopoulos, G; Panitti, E; Latsou, D.

Afiliação

Yfantopoulos J; National and Kapodistrian University of Athens, Athens, Greece.
Hatzikou M; Novartis Hellas, Metamorfosis, Greece.
Rombopoulos G; Novartis Hellas, Metamorfosis, Greece.
Panitti E; Novartis Hellas, Metamorfosis, Greece.
Latsou D; University of Peloponnese, Corinth, Greece Hypoglycemia (Hypo) is a common adverse effect of type 2 diabetes (T2D) therapy. Hypo has a negative impact on health care resources and quality of life (QoL) and can affect compliance and T2D control.

Value Health ; 17(7): A356, 2014 Nov.

Article em En | MEDLINE | ID: mdl-27200711

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Value Health Assunto da revista: FARMACOLOGIA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Grécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google